Keros Therapeutics

OverviewSuggest Edit

Keros Therapeutics is a biotechnology company dedicated to the discovery and development of novel therapeutics for neuromuscular diseases. The Company's first program is focused on the inhibition of activin receptor-like kinase-2 (ALK2), a human protein that is the genetic driver for FOP; its second program is focused on treatments to strengthen muscle and improve function in multiple muscle disorders.

TypePrivate
Founded2015
HQCambridge, US
Websitekerostx.com

Locations

Keros Therapeutics is headquartered in
Cambridge, United States

Location Map

Latest Updates

Employees (est.) (Nov 2019)19

Keros Therapeutics Office Locations

Keros Therapeutics has an office in Cambridge
Cambridge, US (HQ)
215 First St #500
Show all (1)

Keros Therapeutics Financials and Metrics

Summary Metrics

Founding Date

2015

Keros Therapeutics total Funding

$34 m

Keros Therapeutics latest funding size

$23 m

Time since last funding

10 months ago

Keros Therapeutics investors

Keros Therapeutics's latest funding round in January 2019 was reported to be $23 m. In total, Keros Therapeutics has raised $34 m
Show all financial metrics

Keros Therapeutics Online and Social Media Presence

Embed Graph

Keros Therapeutics Frequently Asked Questions

  • When was Keros Therapeutics founded?

    Keros Therapeutics was founded in 2015.

  • How many employees does Keros Therapeutics have?

    Keros Therapeutics has 19 employees.

  • Who are Keros Therapeutics competitors?

    Competitors of Keros Therapeutics include Strand Therapeutics, Actuate Therapeutics and Imara.

  • Where is Keros Therapeutics headquarters?

    Keros Therapeutics headquarters is located at 215 First St #500, Cambridge.

  • Where are Keros Therapeutics offices?

    Keros Therapeutics has an office in Cambridge.

  • How many offices does Keros Therapeutics have?

    Keros Therapeutics has 1 office.